261 related articles for article (PubMed ID: 10574969)
1. Histone deacetylase inhibition selectively alters the activity and expression of cell cycle proteins leading to specific chromatin acetylation and antiproliferative effects.
Sambucetti LC; Fischer DD; Zabludoff S; Kwon PO; Chamberlin H; Trogani N; Xu H; Cohen D
J Biol Chem; 1999 Dec; 274(49):34940-7. PubMed ID: 10574969
[TBL] [Abstract][Full Text] [Related]
2. [Regulation of histone acetylation on the expression of cell cycle-associated genes in human colon cancer cell lines].
Chen YX; Fang JY; Lu J; Qiu DK
Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):312-7. PubMed ID: 15059516
[TBL] [Abstract][Full Text] [Related]
3. Rapid induction of histone hyperacetylation and cellular differentiation in human breast tumor cell lines following degradation of histone deacetylase-1.
Zhou Q; Melkoumian ZK; Lucktong A; Moniwa M; Davie JR; Strobl JS
J Biol Chem; 2000 Nov; 275(45):35256-63. PubMed ID: 10938272
[TBL] [Abstract][Full Text] [Related]
4. Butyrate, an HDAC inhibitor, stimulates interplay between different posttranslational modifications of histone H3 and differently alters G1-specific cell cycle proteins in vascular smooth muscle cells.
Mathew OP; Ranganna K; Yatsu FM
Biomed Pharmacother; 2010 Dec; 64(10):733-40. PubMed ID: 20970954
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation.
Richon VM; Sandhoff TW; Rifkind RA; Marks PA
Proc Natl Acad Sci U S A; 2000 Aug; 97(18):10014-9. PubMed ID: 10954755
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of MDA-MB-231 breast cancer cell proliferation and tumor growth by apigenin through induction of G2/M arrest and histone H3 acetylation-mediated p21
Tseng TH; Chien MH; Lin WL; Wen YC; Chow JM; Chen CK; Kuo TC; Lee WJ
Environ Toxicol; 2017 Feb; 32(2):434-444. PubMed ID: 26872304
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional activation of p21(WAF1/CIP1) by apicidin, a novel histone deacetylase inhibitor.
Kim JS; Lee S; Lee T; Lee YW; Trepel JB
Biochem Biophys Res Commun; 2001 Mar; 281(4):866-71. PubMed ID: 11237739
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase inhibitors activate p21(WAF1) expression via ATM.
Ju R; Muller MT
Cancer Res; 2003 Jun; 63(11):2891-7. PubMed ID: 12782595
[TBL] [Abstract][Full Text] [Related]
9. Histone H3 acetylation is associated with reduced p21(WAF1/CIP1) expression by gastric carcinoma.
Mitani Y; Oue N; Hamai Y; Aung PP; Matsumura S; Nakayama H; Kamata N; Yasui W
J Pathol; 2005 Jan; 205(1):65-73. PubMed ID: 15586362
[TBL] [Abstract][Full Text] [Related]
10. The tumor suppressor p53 and histone deacetylase 1 are antagonistic regulators of the cyclin-dependent kinase inhibitor p21/WAF1/CIP1 gene.
Lagger G; Doetzlhofer A; Schuettengruber B; Haidweger E; Simboeck E; Tischler J; Chiocca S; Suske G; Rotheneder H; Wintersberger E; Seiser C
Mol Cell Biol; 2003 Apr; 23(8):2669-79. PubMed ID: 12665570
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter.
Yokota T; Matsuzaki Y; Miyazawa K; Zindy F; Roussel MF; Sakai T
Oncogene; 2004 Jul; 23(31):5340-9. PubMed ID: 15107822
[TBL] [Abstract][Full Text] [Related]
12. Oestrogen receptor alpha increases p21(WAF1/CIP1) gene expression and the antiproliferative activity of histone deacetylase inhibitors in human breast cancer cells.
Margueron R; Licznar A; Lazennec G; Vignon F; Cavaillès V
J Endocrinol; 2003 Oct; 179(1):41-53. PubMed ID: 14529564
[TBL] [Abstract][Full Text] [Related]
13. Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter-associated proteins, including HDAC1.
Gui CY; Ngo L; Xu WS; Richon VM; Marks PA
Proc Natl Acad Sci U S A; 2004 Feb; 101(5):1241-6. PubMed ID: 14734806
[TBL] [Abstract][Full Text] [Related]
14. TGF-beta-mediated cell cycle arrest of HPV16-immortalized human ectocervical cells correlates with decreased E6/E7 mRNA and increased p53 and p21(WAF-1) expression.
Rorke EA; Zhang D; Choo CK; Eckert RL; Jacobberger JW
Exp Cell Res; 2000 Aug; 259(1):149-57. PubMed ID: 10942587
[TBL] [Abstract][Full Text] [Related]
15. A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase.
Myzak MC; Karplus PA; Chung FL; Dashwood RH
Cancer Res; 2004 Aug; 64(16):5767-74. PubMed ID: 15313918
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic regulation of vascular smooth muscle cell proliferation and neointima formation by histone deacetylase inhibition.
Findeisen HM; Gizard F; Zhao Y; Qing H; Heywood EB; Jones KL; Cohn D; Bruemmer D
Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):851-60. PubMed ID: 21233448
[TBL] [Abstract][Full Text] [Related]
17. Functional interplay between modulation of histone deacetylase activity and its regulatory role in G2-M transition.
Noh EJ; Lee JS
Biochem Biophys Res Commun; 2003 Oct; 310(2):267-73. PubMed ID: 14521905
[TBL] [Abstract][Full Text] [Related]
18. Green tea polyphenols causes cell cycle arrest and apoptosis in prostate cancer cells by suppressing class I histone deacetylases.
Thakur VS; Gupta K; Gupta S
Carcinogenesis; 2012 Feb; 33(2):377-84. PubMed ID: 22114073
[TBL] [Abstract][Full Text] [Related]
19. The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation.
Hinnebusch BF; Meng S; Wu JT; Archer SY; Hodin RA
J Nutr; 2002 May; 132(5):1012-7. PubMed ID: 11983830
[TBL] [Abstract][Full Text] [Related]
20. Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21(Waf1/Cip1).
Zhao Y; Lu S; Wu L; Chai G; Wang H; Chen Y; Sun J; Yu Y; Zhou W; Zheng Q; Wu M; Otterson GA; Zhu WG
Mol Cell Biol; 2006 Apr; 26(7):2782-90. PubMed ID: 16537920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
